Cure of chronic prostatitis presumably due to Enterococcus spp and gram-negative bacteria

No abstract is available for this paper.

• Publication year

  2006

• Venue

  European Journal of Clinical Microbiology and Infectious Diseases

• Publication date

  2006-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10096-006-0128-9PMID 16583186
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ciprofloxacin or Tamsulosin in Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Randomized, Double-Blind Trial

  2005cited by this paper
• Inconsistent localization of gram-positive bacteria to prostate-specific specimens from patients with chronic prostatitis.

  2005cited by this paper
• Ciprofloxacin or Tamsulosin in Men with Chronic Prostatitis/Chronic Pelvic Pain Syndrome

  2004cited by this paper
• Peripheral neuropathy associated with prolonged use of linezolid.

  2004cited by this paper
• Penetration of Antimicrobial Agents into the Prostate

  2003cited by this paper
• In vitro antibacterial activity of moxifloxacin against hospital isolates: a multicentre study.

  2003cited by this paper
• Assessment of radioactive residues arising from radiolabel instability in a multiple dose tissue distribution study in rats.

  2003cited by this paper
• Linezolid: a review of its use in the management of serious gram-positive infections.

  2001cited by this paper
• Treatment Options for Chronic Prostatitis due to Vancomycin-Resistant Enterococcus faecium

  1998cited by this paper
• Principles and practice of infectious diseases. Vols 1 and 2.

  1979cited by this paper

• Surgical management of National Institutes of Health category II chronic bacterial prostatitis: a case series and scoping review of the literature

  2023cites this paper
• Safety considerations with new antibacterial approaches for chronic bacterial prostatitis

  2021cites this paper
• Treatment of Bacterial Prostatitis: Clinico-Pharmacological Considerations

  2016cites this paper
• Clinical aspects of phage therapy.

  2012cites this paper
• Antibiotic susceptibility in prostate‐derived Propionibacterium acnes isolates

  2012cites this paper
• The perspectives of the application of phage therapy in chronic bacterial prostatitis.

  2010influential citation
• Eradication of Enterococcus faecalis by phage therapy in chronic bacterial prostatitis — case report

  2009cites this paper
• Chronic bacterial prostatitis and relapsing Enterococcus faecalis bacteraemia successfully treated with moxifloxacin.

  2008cites this paper